Companies Cencora, Inc.
Cencora (COR): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Cencora, Inc.’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO vs. named peers39th pct.Of 18 peer CEOs
CEO pay, last three years
- $7,697,850FY2023
- $9,253,192FY2024
- $18,256,227FY2025
CEO total pay was $18,256,227 in fiscal 2025, up from $9,253,192 in fiscal 2024.
FY2025: salary $1,350,000 · bonus $0 · stock awards $12,000,218 · option awards $0
Executives and directors
Elizabeth Campbell · General CounselJames Cleary · CFORobert Mauch · CEOSilvana Battaglia · ExecutiveSteven Collis · Executive ChairmanD. Mark Durcan · Chair of the BoardDennis M. Nally · Independent DirectorEllen G. Cooper · Independent DirectorFrank K. Clyburn · Independent DirectorKathleen W. Hyle · Former director (through FY2025)Lauren M. Tyler · Independent DirectorLon R. Greenberg · Independent DirectorLorence H. Kim, M.D · Independent DirectorLori J. Ryerkerk · Independent DirectorOrnella Barra · Former director (through FY2025)Redonda G. Miller, M.D · Independent DirectorRichard W. Gochnauer · Former director (through FY2025)Werner Baumann · Independent Director
Frequently asked questions
Who was the highest-paid executive at Cencora, Inc. in fiscal 2025?
As disclosed, Robert Mauch (President and Chief Executive Officer) was the highest-paid executive at Cencora, Inc. in fiscal 2025, with total compensation of $18,256,227.
How does Cencora, Inc.'s chief executive pay compare to its disclosed peer group?
As disclosed, Robert Mauch's total compensation ranked at the 39th percentile of Cencora, Inc.'s disclosed peer group.
What is Cencora, Inc.'s CEO-to-median employee pay ratio?
As disclosed, Cencora, Inc.'s CEO-to-median employee pay ratio was 198:1.
How did shareholders vote on Cencora, Inc.'s executive compensation?
As disclosed, 92.98% of shareholders supported Cencora, Inc.'s executive compensation in the latest say-on-pay vote.
How much does Cencora, Inc. spend in total on board compensation for fiscal 2025?
As disclosed, Cencora, Inc. reported total board compensation of $3,209,459 for fiscal 2025.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Robert Mauch | $1,350,000 | $0 | $12,000,218 | $0 | $4,283,213 | $0 | $622,796 | $18,256,227 |
| President and Chief Executive Officer | ||||||||
| Steven Collis | 1,000,000 | 0 | 6,000,230 | 0 | 1,813,000 | 0 | 867,005 | 9,680,235 |
| Executive Chairman | ||||||||
| James Cleary | 926,137 | 0 | 3,800,000 | 0 | 1,679,087 | 0 | 116,503 | 6,521,727 |
| Executive Vice President and Chief Financial Officer | ||||||||
| Elizabeth Campbell | 769,205 | 0 | 2,900,160 | 0 | 1,394,570 | 0 | 112,733 | 5,176,668 |
| Executive Vice President and Chief Legal Officer | ||||||||
| Silvana Battaglia | 664,849 | 0 | 1,700,454 | 0 | 1,205,372 | 0 | 92,718 | 3,663,393 |
| Executive Vice President and Chief Human Resources Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Robert Mauch | $18,256,227 | $9,253,192 | $7,697,850 | ↑ +9,003,035 |
| Steven Collis | 9,680,235 | 18,475,171 | 17,511,240 | ↓ −8,794,936 |
| James Cleary | 6,521,727 | 9,003,960 | 5,449,373 | ↓ −2,482,233 |
| Elizabeth Campbell | 5,176,668 | 7,669,064 | 4,027,232 | ↓ −2,492,396 |
| Silvana Battaglia | 3,663,393 | 5,320,212 | 2,976,306 | ↓ −1,656,819 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The Compensation Committee supports a compensation philosophy for our NEOs that: [bullet points follow] We emphasize a compensation philosophy that rewards our executive officers when they deliver targeted financial results and subjects a significant portion of their compensation to risk if they do not.
| CEO STI target (% of salary) | 175% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Pearl Meyer & Partners |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | True |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Steven Collis | RSU | 2024-11-20 | — | — | 9,869 | — | $2,400,140 |
| Robert Mauch | PSU | 2024-11-20 | 14,803 | 29,606 | — | 68,094 | 7,200,179 |
| Elizabeth Campbell | RSU | 2024-11-20 | — | — | 4,770 | — | 1,160,064 |
| Elizabeth Campbell | PSU | 2024-11-20 | 3,578 | 7,155 | — | 16,457 | 1,740,096 |
| Silvana Battaglia | PSU | 2024-11-20 | 2,098 | 4,195 | — | 9,649 | 1,020,224 |
| Robert Mauch | RSU | 2024-11-20 | — | — | 19,737 | — | 4,800,039 |
| James Cleary | PSU | 2024-11-20 | 4,688 | 9,375 | — | 21,563 | 2,280,000 |
| Steven Collis | PSU | 2024-11-20 | 7,402 | 14,803 | — | 34,047 | 3,600,090 |
| James Cleary | RSU | 2024-11-20 | — | — | 6,250 | — | 1,520,000 |
| Silvana Battaglia | RSU | 2024-11-20 | — | — | 2,797 | — | 680,230 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Steven Collis | $2,400,140 | $3,600,090 | $0 | 60.0% |
| Robert Mauch | 4,800,039 | 7,200,179 | 0 | 60.0% |
| Elizabeth Campbell | 1,160,064 | 1,740,096 | 0 | 60.0% |
| Silvana Battaglia | 680,230 | 1,020,224 | 0 | 60.0% |
| James Cleary | 1,520,000 | 2,280,000 | 0 | 60.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Silvana Battaglia | RSU | 1,265 | — | $395,350 |
| Elizabeth Campbell | RSU | 2,023 | — | 632,248 |
| Silvana Battaglia | RSU | 2,169 | — | 677,878 |
| Silvana Battaglia | RSU | 2,797 | — | 874,146 |
| James Cleary | RSU | 2,951 | — | 922,276 |
| Elizabeth Campbell | RSU | 3,660 | — | 1,143,860 |
| Robert Mauch | RSU | 4,215 | — | 1,317,314 |
| Elizabeth Campbell | RSU | 4,770 | — | 1,490,768 |
| James Cleary | RSU | 4,879 | — | 1,524,834 |
| James Cleary | RSU | 6,043 | — | 1,888,619 |
| Robert Mauch | RSU | 8,131 | — | 2,541,181 |
| Silvana Battaglia | RSU | 8,415 | — | 2,629,940 |
| Steven Collis | RSU | 9,474 | — | 2,960,909 |
| Silvana Battaglia | PSU | 9,649 | — | 3,015,602 |
| Steven Collis | RSU | 10,536 | — | 3,292,816 |
| Silvana Battaglia | PSU | 11,222 | — | 3,507,212 |
| James Cleary | RSU | 12,623 | — | 3,945,066 |
| Elizabeth Campbell | RSU | 12,623 | — | 3,945,066 |
| Silvana Battaglia | RSU | 14,646 | — | 4,577,314 |
| Elizabeth Campbell | PSU | 16,457 | — | 5,143,306 |
| Steven Collis | RSU | 16,939 | — | 5,293,946 |
| Robert Mauch | Option | 18,814 | 86.09 | — |
| Elizabeth Campbell | PSU | 18,936 | — | 5,918,068 |
| Robert Mauch | RSU | 18,948 | — | 5,921,818 |
| Silvana Battaglia | PSU | 20,871 | — | 6,522,814 |
| James Cleary | PSU | 21,563 | — | 6,739,084 |
| Elizabeth Campbell | RSU | 23,076 | — | 7,211,942 |
| James Cleary | PSU | 25,247 | — | 7,890,445 |
| Steven Collis | PSU | 34,047 | — | 10,640,709 |
| Elizabeth Campbell | PSU | 35,393 | — | 11,061,374 |
| Robert Mauch | PSU | 42,076 | — | 13,150,012 |
| James Cleary | Option | 45,154 | 86.09 | — |
| Steven Collis | Option | 58,699 | 86.09 | — |
| Robert Mauch | PSU | 68,094 | — | 21,281,418 |
| Steven Collis | PSU | 87,658 | — | 27,395,755 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Frank K. ClyburnIndependent · Compliance and Risk · Finance | $110,000 | $286,436 | $0 | — | $0 | $396,436 |
| Redonda G. Miller, M.DIndependent · Compliance and Risk (Chair) · Governance, Sustainability and Corporate Responsibility · Special Litigation | 185,000 | 200,225 | 0 | — | 0 | 385,225 |
| Werner BaumannIndependent · Audit (Chair) · Compensation and Succession Planning · Executive · Special Litigation (Chair) | 182,870 | 200,225 | 0 | — | 0 | 383,095 |
| D. Mark DurcanIndependent · Board Chair · Executive (Chair) | 125,000 | 250,217 | 0 | — | 0 | 375,217 |
| Lauren M. TylerIndependent · Audit · Governance, Sustainability and Corporate Responsibility · Special Litigation | 160,715 | 200,225 | 0 | — | 0 | 360,940 |
| Dennis M. NallyIndependent · Audit · Compensation and Succession Planning (Chair) | 145,481 | 200,225 | 0 | — | 0 | 345,706 |
| Lorence H. Kim, M.DIndependent · Compensation and Succession Planning · Executive · Finance (Chair) | 130,000 | 200,225 | 0 | — | 0 | 330,225 |
| Lon R. GreenbergIndependent · Compliance and Risk · Executive · Finance · Governance, Sustainability and Corporate Responsibility (Chair) | 130,000 | 200,225 | 0 | — | 0 | 330,225 |
| Lori J. RyerkerkIndependent · Newly elected | 40,000 | 152,390 | 0 | — | 0 | 192,390 |
| Kathleen W. HyleIndependent · Not standing for re-election · Departed during FY | 60,000 | — | 0 | — | 0 | 60,000 |
| Richard W. GochnauerIndependent · Not standing for re-election · Departed during FY | 50,000 | — | 0 | — | 0 | 50,000 |
| Robert P. MauchEmployee director · Executive | 0 | 0 | 0 | — | 0 | 0 |
| Steven H. CollisEmployee director · Departed during FY | 0 | 0 | 0 | — | 0 | 0 |
| Ornella BarraNot independent · Departed during FY | 0 | 0 | 0 | — | 0 | 0 |
| Ellen G. CooperIndependent · Newly elected | 0 | 0 | 0 | — | 0 | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $120,000 |
|---|---|
| Annual equity retainer | $250,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 20,000 / 20,000 |
| Stock ownership guideline | 5 times annual cash retainer |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $1,319,066 |
| Equity awards (grant-date value) | $1,890,393 |
| All other compensation | $0 |
| Total cost of the board | $3,209,459 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Cencora as a peer
Companies that benchmark against COR
12 companies name COR as a compensation peer
The list of companies that name COR as a peer is temporarily unavailable — recheck shortly.
Disclosed peer group — fiscal year 2025
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
LLY Eli Lilly and CompanyCAH Cardinal Health, Inc.HSIC Henry Schein, Inc.MCK McKesson CorporationFDX FedEx CorporationTGT Target CorporationCI The Cigna GroupIQV IQVIA Holdings Inc.VTRS Viatris Inc.HCA HCA Healthcare, Inc.CVS CVS Health CorporationSYY Sysco CorporationDGX Quest Diagnostics IncorporatedKR The Kroger Co.UPS United Parcel Service, Inc.HUM Humana Inc.LH Labcorp Holdings Inc.WBA Walgreens Boots Alliance, Inc.
Peer reciprocity
Of the companies Cencora, Inc. names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
— Eli Lilly and Company (LLY)102✓ Cardinal Health, Inc. (CAH)103✓ Henry Schein, Inc. (HSIC)104 McKesson Corporation (MCK) FedEx Corporation (FDX)— Target Corporation (TGT)105✓ The Cigna Group (CI)106— IQVIA Holdings Inc. (IQV)107— Viatris Inc. (VTRS)108✓ HCA Healthcare, Inc. (HCA)109 CVS Health Corporation (CVS)— Sysco Corporation (SYY)110— Quest Diagnostics Incorporated (DGX)111 The Kroger Co. (KR)— United Parcel Service, Inc. (UPS)112✓ Humana Inc. (HUM)113— Labcorp Holdings Inc. (LH)114— Walgreens Boots Alliance, Inc. (WBA)115
Reciprocity shown where the peer’s own current proxy has been read — each mark is cited in the register to that peer’s filing. A dash means the peer’s current proxy was read and names no reciprocal group including Cencora, Inc..
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly and Company | 2025 | David Ricks | $1,700,000 | $23,325,000 | $0 | $6,485,500 | $36,698,337 |
| 2 | Iqvia Holdings Inc. | 2025 | Ari Bousbib | 1,800,000 | 15,749,957 | 4,528,317 | 4,966,127 | 28,128,245 |
| 3 | FedEx Corporation | 2026 | Rajesh Subramaniam | 1,550,000 | 6,731,364 | 3,715,062 | 10,593,500 | 27,554,018 |
| 4 | HCA Healthcare, Inc. | 2025 | Samuel Hazen | 1,577,815 | 8,474,543 | 8,514,090 | 5,416,732 | 26,456,606 |
| 5 | McKesson Corporation | 2026 | Brian Tyler | 1,591,667 | 17,201,202 | 0 | 4,456,668 | 24,213,044 |
| 6 | United Parcel Service, Inc. | 2025 | Carol Tomé | 1,509,713 | 17,550,546 | 1,358,754 | 2,264,569 | 22,878,788 |
| 7 | The Cigna Group | 2025 | David Cordani | 1,600,000 | 13,929,161 | 3,400,019 | 3,200,000 | 22,866,134 |
| 8 | Cardinal Health, Inc. | 2026 | Jason Hollar | 1,500,000 | 16,259,918 | 0 | 4,278,750 | 22,574,349 |
| 9 | CVS Health Corporation | 2025 | J. David Joyner | 1,500,000 | 14,499,931 | 0 | 4,695,900 | 21,214,084 |
| 10 | Humana Inc. | 2025 | James Rechtin | 1,348,558 | 13,868,141 | 0 | 3,034,740 | 18,757,075 |
| 11 | Labcorp Holdings Inc. | 2025 | Adam Schechter | 1,435,000 | 11,400,463 | 2,754,582 | 2,062,095 | 18,339,913 |
| 12 | Cencora, Inc. | 2025 | Robert Mauch | 1,350,000 | 12,000,218 | 0 | 4,283,213 | 18,256,227 |
| 13 | Sysco Corporation | 2026 | Kevin Hourican | 1,435,538 | 10,391,759 | 2,579,986 | 2,905,602 | 17,899,369 |
| 14 | Quest Diagnostics Incorporated | 2025 | James Davis | 1,250,000 | 8,762,861 | 2,999,873 | 2,205,844 | 15,498,479 |
| 15 | Viatris Inc. | 2025 | Scott Smith | 1,448,654 | 10,150,013 | 0 | 2,973,660 | 15,273,331 |
| 16 | The Kroger Co. | 2025 | Ronald L. Sargent | 3,975,806 | 10,000,077 | — | — | 14,037,608 |
| 17 | Walgreens Boots Alliance, Inc. | 2024 | Timothy Wentworth | 1,290,385 | 11,600,744 | 0 | 0 | 13,282,800 |
| 18 | Henry Schein, Inc. | 2025 | Stanley Bergman | 1,707,000 | 7,764,800 | 0 | 2,289,251 | 12,013,915 |
| 19 | Target Corporation | 2025 | Michael Fiddelke | 1,065,385 | 7,853,253 | 0 | 300,882 | 9,598,071 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Cencora, Inc. | 181.3% | PSU 60 · RSU 40 | Yes — Relative TSR | Pearl Meyer & Partners |
| Cardinal Health, Inc. | not disclosed | PSU 60 · RSU 40 | Yes — Relative TSR modifier | Korn Ferry |
| CVS Health Corporation | 156.5% | PSU 60 · RSU 20 · Options 20 | Yes — rTSR Modifier | Korn Ferry |
| Eli Lilly and Company | 218% | PSU 100 | No | FW Cook |
| FedEx Corporation | 112.5% | not disclosed | Yes — Relative TSR (FY24-FY26 LTI Cash Plan) | Meridian Compensation Partners, LLC |
| HCA Healthcare, Inc. | 195.78% | SAR 50 · PSU 50 | No | Semler Brossy |
| Henry Schein, Inc. | 89.3% | PSU 65 · RSU 35 | No | Pearl Meyer |
| Humana Inc. | 112% | PSU 60 · RSU 40 | Yes — Relative TSR | Farient Advisors, LLC |
| Iqvia Holdings Inc. | not disclosed | PSU 75 · Options 25 | Yes | Meridian Compensation Partners, LLC |
| Labcorp Holdings Inc. | 95.8% | PSU 60 · RSU 20 · Options 20 | Yes — RELATIVE TSR MODIFIER | FW Cook |
| McKesson Corporation | 140% | PSU 60 · RSU 40 | Yes — Total Shareholder Return (TSR) relative to comparator group | Korn Ferry |
| Quest Diagnostics Incorporated | 113.9% | PSU 50 · RSU 25 · Options 25 | Yes — Relative TSR | Semler Brossy |
| Sysco Corporation | 115.66% | PSU 50 · RSU 30 · Option 20 | No | Semler Brossy |
| Target Corporation | not disclosed | PSU 60 · PBRSU 40 | No | Semler Brossy |
| The Cigna Group | 100% | PSU 60 · RSU 20 · Options 20 | No | Pay Governance |
| The Kroger Co. | 93.84% | not disclosed | Yes — Value creation (iTSR) | Korn Ferry; Meridian Compensation Partners, LLC |
| United Parcel Service, Inc. | 75% | PSU 93 · Options 7 | Yes — Relative Total Shareowner Return (RTSR) | FW Cook |
| Viatris Inc. | 136.72% | PSU 65 · RSU 35 | No | Meridian Compensation Partners, LLC |
| Walgreens Boots Alliance, Inc. | not disclosed | RSU 100 | not disclosed | Mercer |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-03-05 | 156,852,214 | 11,422,390 | 427,407 | 92.98% | Passed |
| 2025 | 2025-03-06 | 156,885,713 | 12,269,867 | 187,486 | 92.75% | Passed |
| 2024 | 2024-03-12 | 164,272,546 | 10,905,767 | 533,149 | 93.77% | Passed |
| 2023 | 2023-03-09 | 167,879,511 | 7,418,048 | 503,116 | 95.77% | Passed |
| 2022 | 2022-03-10 | 174,566,803 | 8,079,219 | 391,816 | 95.58% | Passed |
| 2021 | 2021-03-11 | 91,818,540 | 85,990,782 | 494,902 | 51.64% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-03-05 | 92.98%a |
| 2025 | 2025-03-06 | 92.75%b |
| 2024 | 2024-03-12 | 93.77%c |
a. Approved under the standard stated in the filing — “2 Advisory vote to approve the fiscal 2025 compensation of Cencora's named executive officers For Majority of shares present and entitled to vote on the matter (3) Counted "against" No effect”.
b. Approved under the standard stated in the filing — “Abstentions and broker non-votes have no effect in determining if a majority of the votes have been cast in favor of a director.”.
c. Approved under the standard stated in the filing — “Abstentions and broker non-votes have no effect in determining if a majority of the votes have been cast in favor of a director.”.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 198 : 1 |
|---|---|
| CEO total compensation | $18,256,227 |
| Median employee compensation | $92,438 |
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Lauren M. Tyler | Director | 2026-01-30 | A | 84 | $359 | $30,174 | Common | Form 4 ↗ |
| Dennis M. Nally | Director | 2026-01-30 | A | 98 | 359 | 35,204 | Common | Form 4 ↗ |
| Ellen G. Cooper | Director | 2026-01-30 | A | 66 | 359 | 23,709 | Common | Form 4 ↗ |
| Ellen G. Cooper | Director | 2026-01-30 | A | 69 | 359 | 24,786 | Common | Form 4 ↗ |
| Robert P. Mauch | Director | 2026-02-18 | D | 1,333 | 359 | 479,160 | Common | Form 4 ↗ |
| Robert P. Mauch | Director | 2026-02-20 | A | 3,762 | 86 | 323,871 | Common | Form 4 ↗ |
| Robert P. Mauch | Director | 2026-02-20 | D | 3,762 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Robert P. Mauch | Director | 2026-02-20 | D | 3,762 | 359 | 1,350,332 | Common | Form 4 ↗ |
| Lori J. Ryerkerk | Director | 2026-03-05 | A | 557 | 359 | 200,119 | Common | Form 4 ↗ |
| Werner Baumann | Director | 2026-03-05 | A | 557 | 359 | 200,119 | Common | Form 4 ↗ |
| Dennis M. Nally | Director | 2026-03-05 | A | 557 | 359 | 200,119 | Common | Form 4 ↗ |
| Ellen G. Cooper | Director | 2026-03-05 | A | 557 | 359 | 200,119 | Common | Form 4 ↗ |
| Frank K. Clyburn | Director | 2026-03-05 | A | 557 | 359 | 200,119 | Common | Form 4 ↗ |
| Redonda Miller | Director | 2026-03-05 | A | 557 | 359 | 200,119 | Common | Form 4 ↗ |
| D. Mark Durcan | Director | 2026-03-05 | A | 905 | 359 | 325,148 | Common | Form 4 ↗ |
| Lon R. Greenberg | Director | 2026-03-05 | A | 557 | 359 | 200,119 | Common | Form 4 ↗ |
| Lauren M. Tyler | Director | 2026-03-05 | A | 557 | 359 | 200,119 | Common | Form 4 ↗ |
| Lorence H. Kim | Director | 2026-03-05 | A | 557 | 359 | 200,119 | Common | Form 4 ↗ |
| James Cleary | Chief Financial Officer | 2026-03-11 | D | 12,623 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Elizabeth Campbell | Executive Vice President | 2026-03-11 | D | 12,623 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Silvana Battaglia | Executive Vice President | 2026-03-11 | D | 8,415 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Silvana Battaglia | Executive Vice President | 2026-03-11 | D | 3,673 | 350 | 1,286,652 | Common | Form 4 ↗ |
| Elizabeth Campbell | Executive Vice President | 2026-03-11 | A | 12,623 | 0 | 0 | Common | Form 4 ↗ |
| Silvana Battaglia | Executive Vice President | 2026-03-11 | A | 8,415 | 0 | 0 | Common | Form 4 ↗ |
| James Cleary | Chief Financial Officer | 2026-03-11 | A | 12,623 | 0 | 0 | Common | Form 4 ↗ |
| James Cleary | Chief Financial Officer | 2026-03-11 | D | 5,409 | 350 | 1,894,773 | Common | Form 4 ↗ |
| Elizabeth Campbell | Executive Vice President | 2026-03-11 | D | 5,842 | 350 | 2,046,453 | Common | Form 4 ↗ |
| Lazarus Krikorian | SVP & Chief Accounting Officer | 2026-04-01 | A | 3,936 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dennis M. Nally | Director | 2026-05-01 | A | 116 | 304 | 35,264 | Common | Form 4 ↗ |
| Lauren M. Tyler | Director | 2026-05-01 | A | 99 | 304 | 30,096 | Common | Form 4 ↗ |
| Ellen G. Cooper | Director | 2026-05-01 | A | 99 | 304 | 30,096 | Common | Form 4 ↗ |
| D. Mark Durcan | Director | 2026-05-28 | A | 4,000 | 266 | 1,065,040 | Common | Form 4 ↗ |
| D. Mark Durcan | Director | 2026-06-18 | A | 4,000 | 274 | 1,096,760 | Common | Form 4 ↗ |
| Lauren M. Tyler | Director | 2026-06-22 | A | 550 | 270 | 148,627 | Common | Form 4 ↗ |
| Eva C. Boratto | Chief Financial Officer | 2026-06-29 | A | 21,304 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Elizabeth Campbell | Executive Vice President | 2026-06-30 | A | 49.89 | 241 | 12,000 | Common | Form 4 ↗ |
| Silvana Battaglia | Executive Vice President | 2026-06-30 | A | 58.2 | 241 | 14,000 | Common | Form 4 ↗ |
| Ellen G. Cooper | Director | 2026-07-31 | A | 97 | 311 | 30,200 | Common | Form 4 ↗ |
| Dennis M. Nally | Director | 2026-07-31 | A | 113 | 311 | 35,181 | Common | Form 4 ↗ |
| Lauren M. Tyler | Director | 2026-07-31 | A | 97 | 311 | 30,200 | Common | Form 4 ↗ |
| Elizabeth Campbell | Executive Vice President | 2026-08-24 | D | 11,300.47 | 324 | 3,662,663 | Common | Form 4 ↗ |
| Lazarus Krikorian | SVP & Chief Accounting Officer | 2026-09-01 | D | 985 | 326 | 321,080 | Common | Form 4 ↗ |
| Lon R. Greenberg | Director | 2026-09-16 | D | 1,280 | 321 | 411,264 | Common | Form 4 ↗ |
| Robert E. Sanchez | Director | 2026-10-01 | A | 275 | — | — | Common | Form 4 ↗ |
| Lazarus Krikorian | SVP & Chief Accounting Officer | 2026-10-01 | D | 986 | 303 | 298,935 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
Sources (115 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Robert Mauch. DEF 14A, filed 2026-01-22. Section “Summary compensation table” · page 69. As printed: 18,256,227. View filing ↗
- Section 01, Steven Collis. DEF 14A, filed 2026-01-22. Section “Summary compensation table”. As printed: 9,680,235. View filing ↗
- Section 01, James Cleary. DEF 14A, filed 2026-01-22. Section “Summary compensation table”. As printed: 6,521,727. View filing ↗
- Section 01, Elizabeth Campbell. DEF 14A, filed 2026-01-22. Section “Summary compensation table”. As printed: 5,176,668. View filing ↗
- Section 01, Silvana Battaglia. DEF 14A, filed 2026-01-22. Section “Summary compensation table”. As printed: 3,663,393. View filing ↗
- Section 03, Steven Collis RSU. DEF 14A, filed 2026-01-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Robert Mauch PSU. DEF 14A, filed 2026-01-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Elizabeth Campbell RSU. DEF 14A, filed 2026-01-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Elizabeth Campbell PSU. DEF 14A, filed 2026-01-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Silvana Battaglia PSU. DEF 14A, filed 2026-01-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Robert Mauch RSU. DEF 14A, filed 2026-01-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, James Cleary PSU. DEF 14A, filed 2026-01-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Steven Collis PSU. DEF 14A, filed 2026-01-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, James Cleary RSU. DEF 14A, filed 2026-01-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Silvana Battaglia RSU. DEF 14A, filed 2026-01-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-01-22. Section “CEO Pay Ratio”. As printed: 198 : 1. View filing ↗
- Section 08, Frank K. Clyburn. DEF 14A, filed 2026-01-22. Section “Director Compensation”. As printed: 396,436. View filing ↗
- Section 08, Redonda G. Miller, M.D. DEF 14A, filed 2026-01-22. Section “Director Compensation”. As printed: 385,225. View filing ↗
- Section 08, Werner Baumann. DEF 14A, filed 2026-01-22. Section “Director Compensation”. As printed: 383,095. View filing ↗
- Section 08, D. Mark Durcan. DEF 14A, filed 2026-01-22. Section “Director Compensation”. As printed: 375,217. View filing ↗
- Section 08, Lauren M. Tyler. DEF 14A, filed 2026-01-22. Section “Director Compensation”. As printed: 360,940. View filing ↗
- Section 08, Dennis M. Nally. DEF 14A, filed 2026-01-22. Section “Director Compensation”. As printed: 345,706. View filing ↗
- Section 08, Lorence H. Kim, M.D. DEF 14A, filed 2026-01-22. Section “Director Compensation”. As printed: 330,225. View filing ↗
- Section 08, Lon R. Greenberg. DEF 14A, filed 2026-01-22. Section “Director Compensation”. As printed: 330,225. View filing ↗
- Section 08, Lori J. Ryerkerk. DEF 14A, filed 2026-01-22. Section “Director Compensation”. As printed: 192,390. View filing ↗
- Section 08, Kathleen W. Hyle. DEF 14A, filed 2026-01-22. Section “Director Compensation”. As printed: 60,000. View filing ↗
- Section 08, Richard W. Gochnauer. DEF 14A, filed 2026-01-22. Section “Director Compensation”. As printed: 50,000. View filing ↗
- Section 08, Robert P. Mauch. DEF 14A, filed 2026-01-22. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Steven H. Collis. DEF 14A, filed 2026-01-22. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Ornella Barra. DEF 14A, filed 2026-01-22. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Ellen G. Cooper. DEF 14A, filed 2026-01-22. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 02, Lauren M. Tyler 2026-01-30. Form 4, filed 2026-03-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dennis M. Nally 2026-01-30. Form 4, filed 2026-03-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ellen G. Cooper 2026-01-30. Form 4, filed 2026-03-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ellen G. Cooper 2026-01-30. Form 4, filed 2026-03-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert P. Mauch 2026-02-18. Form 4, filed 2026-02-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert P. Mauch 2026-02-20. Form 4, filed 2026-02-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert P. Mauch 2026-02-20. Form 4, filed 2026-02-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert P. Mauch 2026-02-20. Form 4, filed 2026-02-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lori J. Ryerkerk 2026-03-05. Form 4, filed 2026-03-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Werner Baumann 2026-03-05. Form 4, filed 2026-03-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dennis M. Nally 2026-03-05. Form 4, filed 2026-03-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ellen G. Cooper 2026-03-05. Form 4, filed 2026-03-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Frank K. Clyburn 2026-03-05. Form 4, filed 2026-03-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Redonda Miller 2026-03-05. Form 4, filed 2026-03-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, D. Mark Durcan 2026-03-05. Form 4, filed 2026-03-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lon R. Greenberg 2026-03-05. Form 4, filed 2026-03-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lauren M. Tyler 2026-03-05. Form 4, filed 2026-03-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lorence H. Kim 2026-03-05. Form 4, filed 2026-03-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, James Cleary 2026-03-11. Form 4, filed 2026-03-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Elizabeth Campbell 2026-03-11. Form 4, filed 2026-03-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Silvana Battaglia 2026-03-11. Form 4, filed 2026-03-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Silvana Battaglia 2026-03-11. Form 4, filed 2026-03-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Elizabeth Campbell 2026-03-11. Form 4, filed 2026-03-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Silvana Battaglia 2026-03-11. Form 4, filed 2026-03-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, James Cleary 2026-03-11. Form 4, filed 2026-03-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, James Cleary 2026-03-11. Form 4, filed 2026-03-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Elizabeth Campbell 2026-03-11. Form 4, filed 2026-03-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lazarus Krikorian 2026-04-01. Form 4, filed 2026-04-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dennis M. Nally 2026-05-01. Form 4, filed 2026-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lauren M. Tyler 2026-05-01. Form 4, filed 2026-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ellen G. Cooper 2026-05-01. Form 4, filed 2026-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, D. Mark Durcan 2026-05-28. Form 4, filed 2026-05-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, D. Mark Durcan 2026-06-18. Form 4, filed 2026-06-22. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lauren M. Tyler 2026-06-22. Form 4, filed 2026-06-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Eva C. Boratto 2026-06-29. Form 4, filed 2026-06-30. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Elizabeth Campbell 2026-06-30. Form 4, filed 2026-07-07. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Silvana Battaglia 2026-06-30. Form 4, filed 2026-07-07. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ellen G. Cooper 2026-07-31. Form 4, filed 2026-08-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dennis M. Nally 2026-07-31. Form 4, filed 2026-08-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lauren M. Tyler 2026-07-31. Form 4, filed 2026-08-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Elizabeth Campbell 2026-08-24. Form 4, filed 2026-08-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lazarus Krikorian 2026-09-01. Form 4, filed 2026-09-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lon R. Greenberg 2026-09-16. Form 4, filed 2026-09-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert E. Sanchez 2026-10-01. Form 4, filed 2026-10-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lazarus Krikorian 2026-10-01. Form 4, filed 2026-10-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-03-06. Item 5.07 · say-on-pay result. As reported: 92.98% (votes for as printed: 156,852,214). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-03-10. Item 5.07 · say-on-pay result. As reported: 92.75% (votes for as printed: 156,885,713). View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-03-15. Item 5.07 · say-on-pay result. As reported: 93.77% (votes for as printed: 164,272,546). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 1,319,066 + equity 1,890,393 + all other 0 = 3,209,459, summed across the director compensation table rows.
- Eli Lilly and Company, Section 10b CEO total. DEF 14A, filed 2026-03-20. CEO total compensation as printed in Eli Lilly and Company's own proxy. As printed: 36,698,337. View filing ↗
- Iqvia Holdings Inc., Section 10b CEO total. DEF 14A, filed 2026-02-27. CEO total compensation as printed in Iqvia Holdings Inc.'s own proxy. As printed: 28,128,245. View filing ↗
- FedEx Corporation, Section 10b CEO total. DEF 14A, filed 2026-08-17. CEO total compensation as printed in FedEx Corporation's own proxy. As printed: 27,554,018. View filing ↗
- HCA Healthcare, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-13. CEO total compensation as printed in HCA Healthcare, Inc.'s own proxy. As printed: 26,456,606. View filing ↗
- McKesson Corporation, Section 10b CEO total. DEF 14A, filed 2026-06-12. CEO total compensation as printed in McKesson Corporation's own proxy. As printed: 24,213,044. View filing ↗
- United Parcel Service, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-19. CEO total compensation as printed in United Parcel Service, Inc.'s own proxy. As printed: 22,878,788. View filing ↗
- The Cigna Group, Section 10b CEO total. DEF 14A, filed 2026-03-13. CEO total compensation as printed in The Cigna Group's own proxy. As printed: 22,866,134. View filing ↗
- Cardinal Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-09-21. CEO total compensation as printed in Cardinal Health, Inc.'s own proxy. As printed: 22,574,349. View filing ↗
- CVS Health Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-03. CEO total compensation as printed in CVS Health Corporation's own proxy. As printed: 21,214,084. View filing ↗
- Humana Inc., Section 10b CEO total. DEFR 14A, filed 2026-03-06. CEO total compensation as printed in Humana Inc.'s own proxy. As printed: 18,757,075. View filing ↗
- Labcorp Holdings Inc., Section 10b CEO total. DEF 14A, filed 2026-04-10. CEO total compensation as printed in Labcorp Holdings Inc.'s own proxy. As printed: 18,339,913. View filing ↗
- Cencora, Inc. (subject), Section 10b CEO total. DEF 14A, filed 2026-01-22. CEO total compensation as printed in Cencora, Inc.'s own proxy. As printed: 18,256,227. View filing ↗
- Sysco Corporation, Section 10b CEO total. DEF 14A, filed 2026-10-01. CEO total compensation as printed in Sysco Corporation's own proxy. As printed: 17,899,369. View filing ↗
- Quest Diagnostics Incorporated, Section 10b CEO total. DEF 14A, filed 2026-04-06. CEO total compensation as printed in Quest Diagnostics Incorporated's own proxy. As printed: 15,498,479. View filing ↗
- Viatris Inc., Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in Viatris Inc.'s own proxy. As printed: 15,273,331. View filing ↗
- The Kroger Co., Section 10b CEO total. DEF 14A, filed 2026-05-13. CEO total compensation as printed in The Kroger Co.'s own proxy. As printed: 14,037,608. View filing ↗
- Walgreens Boots Alliance, Inc., Section 10b CEO total. DEF 14A, filed 2024-12-13. CEO total compensation as printed in Walgreens Boots Alliance, Inc.'s own proxy. As printed: 13,282,800. View filing ↗
- Henry Schein, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-08. CEO total compensation as printed in Henry Schein, Inc.'s own proxy. As printed: 12,013,915. View filing ↗
- Target Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-27. CEO total compensation as printed in Target Corporation's own proxy. As printed: 9,598,071. View filing ↗
- Section 10a, Eli Lilly and Company reciprocity. DEF 14A. Eli Lilly and Company's most recent proxy was read; its disclosed peer group does not include Cencora, Inc.. View filing ↗
- Section 10a, Cardinal Health, Inc. reciprocity. DEF 14A. Cardinal Health, Inc. names Cencora, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Henry Schein, Inc. reciprocity. DEF 14A. Henry Schein, Inc. names Cencora, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Target Corporation reciprocity. DEF 14A. Target Corporation's most recent proxy was read; its disclosed peer group does not include Cencora, Inc.. View filing ↗
- Section 10a, The Cigna Group reciprocity. DEF 14A. The Cigna Group names Cencora, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, IQVIA Holdings Inc. reciprocity. DEF 14A. IQVIA Holdings Inc.'s most recent proxy was read; its disclosed peer group does not include Cencora, Inc.. View filing ↗
- Section 10a, Viatris Inc. reciprocity. DEF 14A. Viatris Inc.'s most recent proxy was read; its disclosed peer group does not include Cencora, Inc.. View filing ↗
- Section 10a, HCA Healthcare, Inc. reciprocity. DEF 14A. HCA Healthcare, Inc. names Cencora, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Sysco Corporation reciprocity. DEF 14A. Sysco Corporation's most recent proxy was read; its disclosed peer group does not include Cencora, Inc.. View filing ↗
- Section 10a, Quest Diagnostics Incorporated reciprocity. DEF 14A. Quest Diagnostics Incorporated's most recent proxy was read; its disclosed peer group does not include Cencora, Inc.. View filing ↗
- Section 10a, United Parcel Service, Inc. reciprocity. DEF 14A. United Parcel Service, Inc.'s most recent proxy was read; its disclosed peer group does not include Cencora, Inc.. View filing ↗
- Section 10a, Humana Inc. reciprocity. DEF 14A. Humana Inc. names Cencora, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Labcorp Holdings Inc. reciprocity. DEF 14A. Labcorp Holdings Inc.'s most recent proxy was read; its disclosed peer group does not include Cencora, Inc.. View filing ↗
- Section 10a, Walgreens Boots Alliance, Inc. reciprocity. DEF 14A. Walgreens Boots Alliance, Inc.'s most recent proxy was read; its disclosed peer group does not include Cencora, Inc.. View filing ↗